Darcey Black is a Founder/Director of TherapeutAix UG, a life sciences consultancy company based in Aachen, Germany, which provides drug discovery and development expertise to a wide range of clients in the pharma and biotech industry. He has over 30 years’ experience in pre-and early clinical drug discovery working in all aspects from target ID and validation, LO and translational studies in early clinical development, and in a range of therapeutic areas. Before founding TherapeutAix, Darcey was Head of External Innovation in the Innovative Medicines Unit, Grünenthal Innovation. Prior to that he worked for Merck (formerly Organon/Schering-Plough) in senior project and line management roles, and at Pfizer, UK, and Glaxo (now GSK) in the UK and Switzerland.